BIOMAT Database Logo BIOMAT Database Logo

Major histocompatibility complex class I deficiency prolongs islet allograft survival. 1993

R W Osorio, and N L Ascher, and R Jaenisch, and C E Freise, and J P Roberts, and P G Stock
Department of Surgery, University of California, San Francisco 94143.

Because of islet allograft rejection, nonimmunosuppressed pancreatic islet allotransplantation has been unsuccessful for the treatment of type I diabetes. The role of major histocompatibility complex class I antigen expression on islet allograft survival was evaluated with the use of mice homozygous for a beta 2-microglobulin gene disruption. These mice express little if any functional major histocompatibility complex class I antigen. When these major histocompatibility complex class I-deficient islets were used as donors in an allogenic murine transplantation model, islet allograft survival was markedly prolonged. These results demonstrate a major importance for the alloresponse directed against major histocompatibility complex class I antigen.

UI MeSH Term Description Entries
D007154 Immune System Diseases Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both. Immune Disorders,Immune System Disorders,Immunologic Diseases,Diseases of Immune System,Immune Diseases,Immunological Diseases,Disease, Immune,Disease, Immune System,Disease, Immunologic,Disease, Immunological,Disorder, Immune System,Immune Disease,Immune Disorder,Immune System Disease,Immune System Disorder,Immunologic Disease,Immunological Disease
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008817 Mice, Mutant Strains Mice bearing mutant genes which are phenotypically expressed in the animals. Mouse, Mutant Strain,Mutant Mouse Strain,Mutant Strain of Mouse,Mutant Strains of Mice,Mice Mutant Strain,Mice Mutant Strains,Mouse Mutant Strain,Mouse Mutant Strains,Mouse Strain, Mutant,Mouse Strains, Mutant,Mutant Mouse Strains,Mutant Strain Mouse,Mutant Strains Mice,Strain Mouse, Mutant,Strain, Mutant Mouse,Strains Mice, Mutant,Strains, Mutant Mouse
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D005260 Female Females
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006720 Homozygote An individual in which both alleles at a given locus are identical. Homozygotes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001613 beta 2-Microglobulin An 11-kDa protein associated with the outer membrane of many cells including LYMPHOCYTES. It is the small subunit of MHC CLASS I MOLECULES. Association with beta 2-microglobulin is generally required for the transport of class I heavy chains from the endoplasmic reticulum to the cell surface. Beta 2-microglobulin is present in small amounts in serum, CEREBROSPINAL FLUID, and urine of healthy individuals, and to a much greater degree in the urine and plasma of patients with tubular PROTEINURIA, renal failure, or kidney transplants. Thymotaxin,beta 2 Microglobulin

Related Publications

R W Osorio, and N L Ascher, and R Jaenisch, and C E Freise, and J P Roberts, and P G Stock
Ex Vivo Major Histocompatibility Complex I Knockdown Prolongs Rejection-free Allograft Survival.
June 2018, Plastic and reconstructive surgery. Global open,
R W Osorio, and N L Ascher, and R Jaenisch, and C E Freise, and J P Roberts, and P G Stock
Major histocompatibility complex antigens and murine islet allograft survival.
January 1991, Transplantation,
R W Osorio, and N L Ascher, and R Jaenisch, and C E Freise, and J P Roberts, and P G Stock
Presentation of donor major histocompatibility complex class II antigens by dna vaccination prolongs heart allograft survival.
March 2004, Transplantation,
R W Osorio, and N L Ascher, and R Jaenisch, and C E Freise, and J P Roberts, and P G Stock
[Major histocompatibility complex class II deficiency].
March 2007, Anales de pediatria (Barcelona, Spain : 2003),
R W Osorio, and N L Ascher, and R Jaenisch, and C E Freise, and J P Roberts, and P G Stock
Effects of class I major histocompatibility complex antigens on hepatic allograft survival in rats: distribution of donor cells which express class I major histocompatibility complex antigens in the recipient.
February 1995, Transplantation proceedings,
R W Osorio, and N L Ascher, and R Jaenisch, and C E Freise, and J P Roberts, and P G Stock
Rapamycin prolongs murine islet allograft survival.
December 1992, Transplantation proceedings,
R W Osorio, and N L Ascher, and R Jaenisch, and C E Freise, and J P Roberts, and P G Stock
Both innate and adaptive major histocompatibility complex class I-dependent immunity impair long-term islet xenograft survival.
March 2008, Transplantation proceedings,
R W Osorio, and N L Ascher, and R Jaenisch, and C E Freise, and J P Roberts, and P G Stock
Human natural killer cells in major histocompatibility complex class I deficiency.
August 2021, Scandinavian journal of immunology,
R W Osorio, and N L Ascher, and R Jaenisch, and C E Freise, and J P Roberts, and P G Stock
Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival.
July 2011, Transplantation,
R W Osorio, and N L Ascher, and R Jaenisch, and C E Freise, and J P Roberts, and P G Stock
T cell recognition of donor major histocompatibility complex class I peptides during allograft rejection.
June 1992, European journal of immunology,
Copied contents to your clipboard!